CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. (“GPCR Therapeutics”) on December 24, 2024, aimed at the acquisition of GPCR USA, a subsidiary of GPCR Therapeutics, and the technology transfer and collaborative research on GPCR Therapeutics’ ongoing drug development pipelines. Through … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#AntiKickbackStatute—Louis J. Cohen, P.C., announces a $15 million settlement of a False Claims Act whistleblower lawsuit against former physician Mohammad Rasekhi, his wife, Sheila Busheri, Southern California Medical Center, Inc. (SCMC), and R & B Medical Group, Inc. dba Universal Diagnostics Laboratories (UDL). The whistleblowers alleged that Rasekhi and Busheri employed a dozen … [Read more…]

Digital Marketing Campaign to Highlight Clinical-Stage Cancer Innovation OST-HER2 that activates cellular immunity against HER2+ cancer OS Therapies Joins the B2i Digital Featured Companies Program NEW YORK–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, has partnered with B2i Digital to enhance investor outreach. B2i … [Read more…]

TOKYO–(BUSINESS WIRE)–#Astellas–Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead DDP”) announced today that it has entered into a drug discovery service agreement with Astellas Pharma, Inc. (HQ: Chuo-Ku, Tokyo, Japan; “Astellas”) to explore new candidate compounds for targeted protein degraders. Axcelead DDP focuses on targeted protein degradation as the next generation of small-molecule … [Read more…]

TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO: 2503) has been honored in two categories—Digital Health and Accessibility & Age Tech—at the CES Innovation Awards® 2025 for its innovative new product, the Electric Salt Spoon. This unique utensil-shaped device enhances the saltiness and umami flavors of low-sodium foods, providing a groundbreaking solution for healthier eating. This … [Read more…]

VANCOUVER, British Columbia & MELBOURNE, Australia–(BUSINESS WIRE)–Proton Intelligence Inc., developing the first-ever Continuous Potassium Monitoring (CKM™) platform, today announced the closing of its $6.95 million USD Seed Financing round joined by SOSV, We Venture Capital, Tenmile, LongeVC, 15th Rock, Exor, and Trampoline Venture Partners. The CKM™ platform is designed to transform the management of cardio-kidney-metabolic … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#HIV–In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare Foundation (AHF) urges global health leaders to prioritize condoms as a critical component of the rollout. While lenacapavir is a groundbreaking tool to reduce HIV transmission, promoting it without a … [Read more…]

MANHASSET, N.Y.–(BUSINESS WIRE)–Nearing five years since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, scientists continue to uncover the risk factors of blood clots and potential death for hospitalized and recently discharged patients with COVID-19. A new international study reveals that therapeutic doses of the common blood thinner heparin could significantly improve the survival … [Read more…]

Funding will provide Company sufficient cash runway into 2026 95% of investment in private placement from Pre-IPO and/or IPO investors Data from OST-HER2 Phase 2b in recurrent, resected metastatic osteosarcoma to be announced during the week of the JP Morgan Healthcare Conference in January 2025 NEW YORK–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or … [Read more…]

NATICK, Mass.–(BUSINESS WIRE)–Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a one-for-twenty five reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The reverse stock split will take effect at … [Read more…]